Rossmax International Ltd (4121) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rossmax International Ltd (4121) has a cash flow conversion efficiency ratio of 0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$87.29 Million ≈ $2.75 Million USD) by net assets (NT$1.98 Billion ≈ $62.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4121 equity financing ratio to measure how much of total assets are equity-financed.
Rossmax International Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Rossmax International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Rossmax International Ltd to evaluate the quality of earnings relative to operating cash generation.
Rossmax International Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rossmax International Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dierig Holding AG
XETRA:DIE
|
0.070x |
|
Plata Latina Minerals Corp
V:PLA
|
-0.097x |
|
Bicicletas Monark S.A
SA:BMKS3
|
0.016x |
|
Shandong Chenming Paper Holdings Limited
F:SCD1
|
0.823x |
|
Hankuk Steel Wire Co. Ltd
KQ:025550
|
-0.012x |
|
New Advanced Electronics Technologies Co Ltd
TWO:3465
|
-0.107x |
|
JCH Systems Inc
KQ:033320
|
0.126x |
|
SHL Telemedicine Ltd American Depositary Shares
NASDAQ:SHLT
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Rossmax International Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Rossmax International Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see 4121 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.98 Billion ≈ $62.50 Million |
NT$284.20 Million ≈ $8.95 Million |
0.143x | -4.73% |
| 2024-12-31 | NT$2.09 Billion ≈ $65.81 Million |
NT$314.10 Million ≈ $9.90 Million |
0.150x | -7.93% |
| 2023-12-31 | NT$1.85 Billion ≈ $58.32 Million |
NT$302.35 Million ≈ $9.53 Million |
0.163x | -26.86% |
| 2022-12-31 | NT$1.94 Billion ≈ $61.26 Million |
NT$434.21 Million ≈ $13.68 Million |
0.223x | -30.94% |
| 2021-12-31 | NT$1.78 Billion ≈ $56.06 Million |
NT$575.43 Million ≈ $18.13 Million |
0.323x | +16.85% |
| 2020-12-31 | NT$1.66 Billion ≈ $52.30 Million |
NT$459.35 Million ≈ $14.47 Million |
0.277x | +349.61% |
| 2019-12-31 | NT$1.33 Billion ≈ $41.95 Million |
NT$81.95 Million ≈ $2.58 Million |
0.062x | +250.29% |
| 2018-12-31 | NT$1.34 Billion ≈ $42.25 Million |
NT$23.56 Million ≈ $742.40K |
0.018x | +124.35% |
| 2017-12-31 | NT$1.35 Billion ≈ $42.61 Million |
NT$-97.57 Million ≈ $-3.07 Million |
-0.072x | -- |
About Rossmax International Ltd
Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listenin… Read more